BamOmaB was founded in 2006 in order to provide newly developed, high-quality reagents for immunological research to the scientific community. These reagents primarily include novel monoclonal antibodies and ELISA-kits developed in the Department of Immunology of the University of Tuebingen. Founders of BAMOMAB are Margret Steinle, Prof. Dr. Hans-Georg Rammensee and Dr. Alexander Steinle.
















BAMOMAB is located in Ruffiniallee 15a, 82166 Gräfelfing , Germany.
Margret Steinle who holds an MBA acts as Managing Director.
For further information, please send an e-mail to info@bamomab.com.